Live price temporarily unavailable.
Alto Ingredients (ALTO) is a Materials company in the Russell 2000. Latest news and coverage below.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.62B | $1.63B | $1.52B | $1.42B | $897.0M | $1.21B | $1.34B | $1.22B | $965.3M | $917.9M |
| Growth (year over year) | +35.8% | +0.5% | −7.2% | −6.0% | −37.0% | +34.7% | +10.6% | −8.4% | −21.1% | −4.9% |
| Gross profit | $54.4M | $5.93M | −$15.2M | −$9.94M | $52.9M | $67.8M | −$27.6M | $15.7M | $9.72M | $34.9M |
| Gross margin | 3.3% | 0.4% | −1.0% | −0.7% | 5.9% | 5.6% | −2.1% | 1.3% | 1.0% | 3.8% |
| Operating income | $23.5M | −$25.6M | −$51.5M | −$74.7M | $9.85M | $40.1M | −$61.4M | −$23.8M | −$51.7M | $7.36M |
| Operating margin | 1.4% | −1.6% | −3.4% | −5.2% | 1.1% | 3.3% | −4.6% | −2.0% | −5.4% | 0.8% |
| Net income | $1.42M | −$35.0M | −$60.3M | −$88.9M | −$15.1M | $46.1M | −$41.6M | −$28.0M | −$59.0M | $13.3M |
| Net margin | 0.1% | −2.1% | −4.0% | −6.2% | −1.7% | 3.8% | −3.1% | −2.3% | −6.1% | 1.5% |
| EPS (diluted) | $0.00 | −$0.85 | −$1.42 | −$1.90 | −$0.28 | $0.61 | −$0.60 | −$0.40 | −$0.82 | $0.16 |
| Balance sheet | ||||||||||
| Cash and equivalents | $64.3M | $49.5M | $26.6M | $19.0M | $47.7M | $50.6M | $36.5M | $30.0M | $35.5M | $23.4M |
| Total assets | $708.2M | $720.3M | $660.0M | $612.5M | $476.8M | $485.0M | $478.3M | $454.2M | $401.4M | $388.8M |
| Total liabilities | $290.0M | $336.6M | $340.6M | $385.4M | $180.6M | $139.7M | $170.2M | $174.7M | $176.4M | $143.5M |
| Long-term debt | $188.0M | $221.1M | $84.8M | $180.8M | $71.8M | $50.4M | $68.4M | $82.1M | $92.9M | $63.0M |
| Shareholders' equity | $387.9M | $356.4M | $319.4M | $227.0M | $296.2M | $345.2M | $308.1M | $279.6M | $225.1M | $245.2M |
| Cash flow | ||||||||||
| Operating cash flow | $37.2M | $36.5M | $1.57M | −$31.2M | $71.7M | $26.8M | $6.05M | $22.0M | −$3.52M | $13.2M |
| Capital expenditure | $19.2M | $20.9M | $15.2M | $3.28M | $6.58M | $16.4M | $37.7M | $29.5M | $11.1M | $4.60M |
| Free cash flow | $18.1M | $15.6M | −$13.6M | −$34.5M | $65.1M | $10.4M | −$31.7M | −$7.51M | −$14.6M | $8.65M |
| Share buybacks | — | — | — | — | — | — | $1.32M | $3.67M | — | — |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $251.8M | $236.3M | $226.5M | $218.4M | $241.0M | $232.0M | $224.7M | $245.7M |
| Growth (year over year) | −20.8% | −13.6% | −5.9% | −7.6% | −4.3% | −1.9% | −0.8% | +12.5% |
| Gross profit | $5.96M | −$1.39M | −$1.81M | −$1.94M | $23.5M | $15.2M | $9.22M | $16.6M |
| Gross margin | 2.4% | −0.6% | −0.8% | −0.9% | 9.7% | 6.5% | 4.1% | 6.8% |
| Operating income | −$720.0K | −$39.2M | −$9.00M | −$8.11M | $17.0M | $7.49M | $2.52M | $8.62M |
| Operating margin | −0.3% | −16.6% | −4.0% | −3.7% | 7.0% | 3.2% | 1.1% | 3.5% |
| Net income | −$2.44M | −$41.7M | −$11.7M | −$11.0M | $14.2M | $21.8M | $4.27M | $11.7M |
| Net margin | −1.0% | −17.6% | −5.2% | −5.0% | 5.9% | 9.4% | 1.9% | 4.8% |
| EPS (diluted) | −$0.04 | −$0.56 | −$0.16 | −$0.15 | $0.19 | $0.28 | $0.05 | $0.15 |
| Balance sheet | ||||||||
| Cash and equivalents | $33.6M | $35.5M | $26.8M | $29.8M | $32.5M | $23.4M | $20.3M | $24.0M |
| Total assets | $417.4M | $401.4M | $402.2M | $393.1M | $388.5M | $388.8M | $386.3M | $397.1M |
| Total liabilities | $153.5M | $176.4M | $188.3M | $185.2M | $166.1M | $143.5M | $136.4M | $137.2M |
| Long-term debt | $83.3M | $92.9M | $110.7M | $118.3M | $100.6M | $63.0M | $73.1M | $60.5M |
| Shareholders' equity | $263.9M | $225.1M | $213.9M | $207.8M | $222.4M | $245.2M | $249.9M | $259.9M |
| Cash flow | ||||||||
| Operating cash flow | $18.6M | −$9.79M | −$18.2M | −$848.0K | $22.8M | $9.54M | $4.21M | $28.5M |
| Capital expenditure | $491.0K | $1.28M | $532.0K | $484.0K | $1.63M | $1.95M | $909.0K | $10.6M |
| Free cash flow | $18.1M | −$11.1M | −$18.8M | −$1.33M | $21.2M | $7.59M | $3.30M | $17.9M |
From Alto Ingredients's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Why Bernstein Still Sees 46% Upside in Zscaler (ZS) but Downgraded Palo Alto (PANW)
Why Bernstein Still Sees 46% Upside in Zscaler (ZS) but Downgraded Palo Alto (PANW)